Skip to content

Effect of Ashvatha Phala Churna and Shveta Palandu Swarasa Bhavita Yavani in Ksheena Shukra(low sperm count)

A Comparative study of Ashvatha Phala Churna and Shveta Palandu Swarasa Bhavita Yavani in the management of Ksheena Shukra w.s.r to Oligozoospermia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/07/006036
Enrollment
40
Registered
2015-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from oligozoospermia

Interventions

Intervention1: Group A virechana with Ashvatha Phala churna: Dosage form powder Dose 3 gm twice a day Mode of Administration Oral Time of Administration Before food in Morning and Night Anupa

Sponsors

IPGT And R A GAU Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Sperm count less than 15 million per ml according to WHO 2010 2 Patient with clinical presentation of Ksheenashukra Oligozoospermia i e Daurbalya Klaibya Shukra Avisarga Pandu etc 3 Patient Yogya for Virechana

Exclusion criteria

Exclusion criteria: 1 Age below 20 and above 50 years 2 Sperm count more than 15 million per ml 3 Patient of azoospermia and aspermia 4 Patients of various diseases like varicocele accessory sex gland infection sexually transmitted diseases severe systemic diseases etc 5 Genetic disorders like Klinfelters syndrome 6 Taking treatment for major psychiatric problem 7 History of previous medications and trauma leading to oligozoospermia 8 Patient Ayogya for virechana

Design outcomes

Primary

MeasureTime frame
The efficacy of the treatment will be assessed on the basis of improvement in the sperm count as well as subjective and objective criteriaTimepoint: 60 days

Secondary

MeasureTime frame
achieving of fertilityTimepoint: 60 days

Countries

India

Contacts

Public ContactVarsakiya Jitendra Nathabhai

IPGT And R A GAU Jamnagar

kaurmandip22@yahoo.com9427572306

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026